Dr. Douglas Ball is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in oncology. His areas of clinical expertise include diagnostic radiology, endocrine oncology, thyroid cancer and thyroid diseases. Dr. Ball earned his M.D. from the George Washington University School of Medicine. He completed his residency at the University of Pittsburgh-Presbyterian University Hospital and performed a fellowship in endocrinology and metabolism at Johns Hopkins. His research interests include medullary thyroid cancer, differentiated thyroid cancer and anaplastic thyroid cancer. Dr. Ball is rated as an Advanced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Medullary Thyroid Carcinoma, Thyroid Cancer, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, and Thyroidectomy.

Dr. Elliot K. Fishman is a Professor in the Johns Hopkins Medicine Department Radiology and Radiological Science, Department of Oncology and Department of Surgery. He serves as a member of the Johns Hopkins Kimmel Cancer Center. His clinical and research interests focus on medical imaging with specific emphasis on three-dimensional (3D) imaging and computed tomography (CT). Dr. Fishman received his B.S. in 1973 and M.D. in 1977 from the University of Maryland. After a residency at Sinai Hospital in Baltimore, he completed a fellowship in CT at Johns Hopkins in 1980 and joined the Johns Hopkins faculty in 1981 as an Assistant Professor. In 1986, he became Associate Professor and, in 1991, Professor of Radiology and Oncology. He is a leader in the development of 3D imaging and rendering, including its impacts on and uses in patient care and management. He was involved from the beginning in the development of 3D imaging through his work with Pixar, which was a spin-off from LucasFilms in San Rafael, California. Over the last 25 years, Dr. Fishman continued to help develop 3D imaging and has been a leader in the development of interactive 3D rendering. His team is consistently at the forefront of research and development of new visualization and post-processing techniques and technologies. Dr. Fishman's extensive body of work in CT has resulted in over 1,000 peer-reviewed publications, and he is the author or co-author of 10 textbooks. He is the recipient of three prestigious Aunt Minnie Awards, honoring his outstanding contributions as both an educator and researcher. In 2007, he was named by Medical Imaging Magazine as the Top Radiologist in the Nation. He is a member of editorial boards for more than 35 journals, an active member of several professional radiology associations and is a past-president of the Society of Body CT/MR. Dr. Fishman is rated as an Advanced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Ductal Adenocarcinoma, Cavernous Lymphangioma, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Meyer will serve as the lead medical oncologist for adult sarcoma patients, and will focus on building the Adult Sarcoma and Connective Tissue Oncology Program. In collaboration with pediatric oncologist David Loeb, M.D., Ph.D., and orthopaedic surgeon Kristy Weber, M.D., Meyer will bring novel therapies to the clinic for sarcoma patients. Meyer received his bachelors and masters degrees in cell and molecular biology from Stanford University. From there, he joined the Medical Scientist Training Program at Baylor College of Medicine and earned his medical degree followed by a doctorate in immunology. Meyer completed his residency at the University of Maryland and served as chief resident in medicine from 2004-2005. Afterward, he joined our fellowship program in medical oncology and has been working in the laboratory of Jonathan Powell, M.D., Ph.D., on projects relating to the characterization of molecular regulatory pathways involved in T-cell activation and energy. As a third-year fellow, Meyer served as the chief fellow for our Training Programs in Hematology and Medical Oncology and he received a Young Investigator Award from the American Society of Clinical Oncology in 2010. Dr. Meyer is rated as an Advanced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Bone Tumor, and Ganglioneuroblastoma.

Norman G. Nicolson, M.D., M.H.S., is an Assistant Professor of Surgery at the Johns Hopkins University School of Medicine and a surgical oncologist within the Division of HPB & Gastrointestinal Surgical Oncology. Dr. Nicolson completed his complex general surgical oncology clinical fellowship training and an NIH-funded T32 research fellowship at Johns Hopkins prior to joining the surgical faculty. Prior to this, he completed his undergraduate work at Williams College and medical degree at Northwestern University, followed by internship and residency in general surgery at Yale New Haven Hospital with a Masters in Health Sciences and research fellowship at Yale University. Dr. Nicolson specializes in treating patients with gastric cancer, peritoneal surface malignancy, appendiceal neoplasms, retroperitoneal sarcoma, gastrointestinal neuroendocrine and stromal tumors, and complex or recurrent tumors of the GI tract. He is trained in both minimally invasive and traditional open approaches to treating these cancers, utilizing laparoscopic or robotic approaches when appropriate. He emphasizes the importance of multi-disciplinary care and patient-centered decision-making, working closely with colleagues in medical and radiation oncology, gastroenterology, and radiology to provide comprehensive personalized cancer care appropriate to each individual. Dr. Nicolson's translational research focuses on computational and bioinformatics approaches to high-dimensional sequencing data from human biospecimens to better understand tumor cell biomarker heterogeneity and the importance of the tumor-draining lymph node in tumor-immune cell interactions in gastrointestinal tumors. He is a member of several academic and clinical professional societies, including the American College of Surgeons, the Association for Academic Surgery, the American Society for Clinical Oncology, the American Association for Cancer Research, and the Society of Surgical Oncology. Dr. Nicolson is rated as an Advanced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Adrenocortical Carcinoma, Adrenal Cancer, Follicular Thyroid Cancer, Pancreaticoduodenectomy, and Thyroidectomy.

Debashish Bose is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Bose is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Pancreatic Pseudocyst, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Bose is currently accepting new patients.

"Dr. Ari D. Fishman is a hematologist affiliated with Sibley Memorial Hospital, Holy Cross Hospital and George Washington University Hospital, where he serves as an assistant professor of medicine for the School of Medicine. He practices out of Maryland Oncology and Hematology, located in Wheaton, Maryland and Silver Spring, Maryland. Dr. Fishman earned his medical degree from Sackler School of Medicine. He completed a residency in internal medicine at the Beth Israel Medical Center, followed by a fellowship in hematology and oncology at the Montefiore Medical Center. Dr. Fishman previously worked at Washington Oncology Hematology Center, located in Washington, D.C. and Chevy Chase, Maryland. Dr. Fishman has been named a Top Doctor in Hematology and Oncology by Washingtonian Magazine and a Top Doctor by Consumers’ Checkbook magazine. Dr. Fishman is a member of the American College of Physicians and the American Society of Clinical Oncology. Dr. Fishman has contributed to numerous publications. Selected Publications Fishman AD, Hoffman A, Volterra F, Frymus M, Gentilluci M. ""Intracaval and intracardiac metastatic nonseminomatous germ cell tumor: a rare cause of hemolytic anemia and thrombocytopenia."" Cancer Invest. 2002;20(7-8):996-1001.". Dr. Fishman is rated as an Advanced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndrome (MDS), and Childhood Iron Deficiency Anemia.

Dr. Prasanna Santhanam received his M.B.B.S. from B.J. Medical College and his M.D. from N.H.L. Municipal Medical College. He completed a residency in internal medicine, Joan C Edwards School of Medicine, Marshall University and a fellowship in endocrinology, diabetes, and metabolism at Joan C Edwards School of Medicine, Marshall University. He underwent additional training in nuclear medicine, at the Department of Radiology and Radiological Sciences at Johns Hopkins University School of Medicine, to pursue his research and clinical interests in nuclear medicine and molecular imaging of endocrine glands and disorders. His clinical interests include thyroid disorders, endocrine neoplasms, and research focus on metabolic and molecular imaging of endocrine tissues and predictive analytics in metabolic disorders. Dr. Santhanam is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Dr. Civelek is a professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. He serves as the director of the Nuclear Medicine Residency Program. Dr. Civelek earned his medical degree at Istanbul University, Istanbul School of Medicine, and completed his residency at Hacettepe University Medical Center, Ankara. He received a scholarship from the International Atomic Energy Agency when he completed his nuclear medicine residency and fellowship at Johns Hopkins in the Division of Nuclear Medicine. After his period as a postdoctoral fellow, he joined Johns Hopkins Medicine as full-time faculty until 2003. In his early years at Johns Hopkins, Dr. Civelek assisted the clinical and research programs. He later served as director of nuclear cardiology and clinical director, the director of Nuclear Medicine Residency Program, as well as medical director of the Nuclear Medicine Technologist Program. Prior to his return to Johns Hopkins, Dr. Civelek was a professor and director of nuclear medicine and PET at the University of Louisville and a professor and director of nuclear medicine at the Saint Louis University Hospital. Dr. Civelek spent two years in the body MRI and MRI-PET section, Department of Radiology and Imaging Sciences, at National Institutes of Health Clinical Center before serving as the deputy chief in their nuclear medicine section. He is a fellow of the American College of Nuclear Medicine and The American College of Angiology, and is a fellow and founding member of the American Society of Nuclear Cardiology. Dr. Civelek has trained numerous American and international physicians in nuclear medicine, including nuclear cardiology and nuclear oncology. He has a worldwide reputation in nuclear medicine and lectures at medical centers in the U.S. and internationally on nuclear medicine, including nuclear cardiology and nuclear oncology/PET-CT and PET-MRI. Dr. Civelek is committed to the continued progress of nuclear medicine, cardiology and oncology and the development of new tumor-targeting radiopharmaceuticals for imaging and therapy. He supports high quality clinical trials and patient care and safety. To date, Dr. Civelek has published more than 210 peer-reviewed manuscripts and abstracts, and he has participated in and fostered many nuclear oncology research projects. He has served on the editorial boards of several journals. He is a reviewer for multiple scientific journals, including the Journal of Nuclear Medicine, American Journal of Radiology, and Journal of Urology. Dr. Civelek is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Neuroendocrine Tumor, Prostate Cancer, Lung Cancer, and Familial Prostate Cancer.

Dr. Linda Chi Hang Chu is an Associate Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. Her clinical expertise includes body CT, MRI and US. Her research interests include abdominal imaging, cancer imaging, radiomics, and artificial intelligence. Dr. Chu graduated from the University of Toronto in 2003 and was awarded the Governor General's Silver Medal, the highest academic achievement from the undergraduate program. She earned her medical degree as a member of AOA and phi beta kappa from Johns Hopkins University in Baltimore, MD in 2007. She completed her Diagnostic Radiology residency and body MRI fellowship at Johns Hopkins Hospital. Dr. Chu joined the Johns Hopkins faculty in 2013. Dr. Chu is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. Her top areas of expertise are Pancreatic Ductal Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Muscle Invasive Bladder Cancer, Pancreaticoduodenectomy, and Gallbladder Removal.

Lilah Morris-Wiseman, M.D., F.A.C.S., is an endocrine surgeon who serves as chief of the Division of Endocrine Surgery. Dr. Morris-Wiseman came to Johns Hopkins in 2021 from the University of Arizona College of Medicine where she was an Associate Professor of Endocrine Surgery. She has a broad endocrine surgery practice using minimally invasive techniques as appropriate to facilitate excellent clinical outcomes with rapid patient recovery. Her clinical practice emphasizes patient-centered shared decision-making and excellent communication and multidisciplinary collaboration so that a patient’s surgical care occurs within an individualized context. She has been named an associate member of the American College of Surgeons' Academy of Master Surgeon Educators. Awardees are recognized for having devoted their careers to surgical education and are considered premier leaders in their respective fields. Dr. Morris-Wiseman holds committee responsibilities with multiple national organizations including the American Thyroid Association, the American Association of Endocrine Surgeons, and the Association of Program Directors in Surgery. She serves on the editorial board of Clinical Thyroidology, is a reviewer for multiple journals, and has published over 50 peer-reviewed manuscripts and book chapters. Dr. Morris-Wiseman sees patients at the Johns Hopkins Outpatient Center in Baltimore and the Johns Hopkins Health Care & Surgery Center – Green Spring Station in Lutherville. To support Dr. Morris-Wiseman's research, visit: https://secure.jhu.edu/form/morris-wiseman. Dr. Morris is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. Her top areas of expertise are Hyperparathyroidism, Familial Isolated Hyperparathyroidism, Osteitis Fibrosa, Thyroidectomy, and Parathyroidectomy.

Dr. Lilja Bjork Solnes is an Assistant Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. Her areas of clinical expertise include diagnostic radiology, oncology, and nuclear medicine. Dr. Solnes serves as the director of Nuclear Medicine and Molecular Imaging as well as the director of Radiotheranostics at the Johns Hopkins School of Medicine. Dr. Solnes received her M.B.A. and M.D. degrees from Columbia University College of Physicians and Surgeons. She completed her radiology residency at Columbia University Medical Center and performed fellowships in Radiology and Neuroradiology at Columbia University. She also completed fellowships from Ohio State University Wexner Medical Center in Neuroradiology and Cornell University Medical Center in Radiology. Dr. Solnes is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. Her top areas of expertise are Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Lymphofollicular Hyperplasia, and Lung Nodules.

Aarti Mathur, M.D., FACS, is an experienced, fellowship-trained endocrine surgeon in the Johns Hopkins Division of Surgical Oncology and an associate professor of surgery at the Johns Hopkins University School of Medicine. Dr. Mathur sees patients at The Johns Hopkins Hospital in Baltimore and at Sibley Memorial Hospital in Washington, D.C. Dr. Mathur earned her medical degree at the University of Texas. She completed a general surgery residency at MedStar Georgetown University Hospital, followed by fellowships at the National Cancer Institute, where she studied immunotherapy and surgical oncology for several years, performed endocrine surgery research and cared for patients with advanced oncologic diseases. Dr. Mathur also completed a fellowship in endocrine surgery at the Johns Hopkins University School of Medicine. Dr. Mathur’s practice exclusively focuses on surgical management of benign and malignant diseases of the thyroid, parathyroid, adrenal glands and cervical lymph nodes. Her expertise includes thyroid surgery for nodules, goiters, Graves disease, thyroid cancer and minimally invasive parathyroidectomy, surgery for persistent or recurrent hyperparathyroidism and laparoscopic adrenalectomy. She believes in providing state of the art, patient-centered multi-disciplinary care for complex endocrine surgical issues. Dr. Mathur serves on multiple committees of major national societies including the American Association of Endocrine Surgeons, the American Thyroid Association, and the American College of Surgeons. As a surgeon-scientist, Dr. Mathur directs a research group, funded by the National Institutes of Health, that studies voice and swallowing outcomes after thyroidectomy in older adults. Her research also focuses on understanding the link between hyperparathyroidism and other health conditions including cognitive impairment, cardiovascular disease and post-transplant outcomes. Dr. Mathur has numerous prestigious national research awards and grants, and she has published over 50 peer reviewed articles, reviews and book chapters. She is frequently invited to present her research at national and international meetings. Dr. Mathur is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. Her top areas of expertise are Hyperparathyroidism, Familial Isolated Hyperparathyroidism, Parathyroid Hyperplasia, Parathyroidectomy, and Thyroidectomy.

Dr. Richard Southard’s specialty is in pediatric radiology, with more than 25 years of experience in private practice and hospital settings. He joins Johns Hopkins from Phoenix Children’s Hospital, where he is vice chief of Radiology Operations. Previously, he served as a pediatric radiologist, partner and president of Radiology Consultants North Dallas, a Texas-based private practice group. He earned his medical degree from The Ohio State University before going on to an internship and residency in pediatric medicine at Nationwide Children’s Hospital, followed by a diagnostic radiology residency at The University of Pittsburgh Medical Center and fellowship in pediatric radiology at Pittsburgh Children’s Hospital. Dr. Southard’s research has focused on CT radiation dose reduction, imaging of congenital heart disease, implementation and validation of iterative reconstruction noise reduction techniques and dual-energy spectral CT applications in children. He joined the pediatric radiology faculty in February 2023 and will be working remotely from Arizona. Dr. Southard is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Tracheobronchopathia Osteoplastica, Bronchogenic Cyst, Dextrocardia, and Collins Pope Syndrome.

Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Satomi Kawamoto is an Associate Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. She specializes in computed tomography (CT), ultrasound, and image-guided biopsy. Dr. Kawamoto received her M.D. from Gunma University in Gunma, Japan, and subsequently completed two residencies, one in internal medicine at St. Luke’s International Hospital in Tokyo, and a second in diagnostic radiology at Johns Hopkins. She received a postdoctoral fellowship in cross-sectional imaging at Johns Hopkins, and then joined the Johns Hopkins faculty. Dr. Kawamoto’s research focuses on body CT and biopsy, particularly imaging of the genitourinary and gastrointestinal systems. Dr. Kawamoto is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. Her top areas of expertise are Neuroendocrine Tumor, Muscle Invasive Bladder Cancer, Cavernous Lymphangioma, Hepato-Pancreato-Biliary Surgery, and Pancreaticoduodenectomy.

Ana De Jesus is an Oncologist in Baltimore, Maryland. Dr. De Jesus is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Narang is an Assistant Professor in the Johns Hopkins Department of Radiation Oncology & Molecular Sciences. A former chief resident in the department, Dr. Narang now specializes in radiation treatment for gastrointestinal malignancies, including pancreatic cancer, colorectal cancer, hepatobiliary malignancies, and gastric cancer. Dr. Narang has an interest in expanding multi-disciplinary care for patients with gastrointestinal malignancies. Make A Gift. Dr. Narang is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Grafe (Gray) Lyons is a specialist in vascular and interventional radiology. His clinical focus is in the diagnosis and treatment of arterial and venous vascular disease and minimally-invasive, image-guided procedures. Dr. Lyons earned a B.S. from Davidson College and M.D. and Ph.D. degrees from Duke University in North Carolina. He completed internship in general surgery and residency in radiology at NewYork-Presbyterian Hospital/Weill Cornell Medicine in New York. He then completed fellowship in vascular and interventional radiology at the Miami Cardiac and Vascular Institute in Florida. Dr. Lyons joined the faculty at Johns Hopkins Medicine in 2019 as an Assistant Professor of Radiology and Radiological Science in the Division of Vascular and Interventional radiology. Dr. Lyons is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, Bile Duct Stricture, Gastrostomy, and Liver Embolization.

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community. CVhttps://www.hopkinsmedicine.org/-/media/profiles-support/cvs/zilbermint.pdfLinkedInhttps://www.linkedin.com/in/mishazilbermint. Dr. Zilbermint is rated as an Experienced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Cushing's syndrome, Familial Hyperaldosteronism, Hyperaldosteronism, Low Blood Sugar, and Thymectomy.

Amir Hamrahian, M.D. is an endocrinologist with specialized experience in the treatment of adrenal and pituitary disorders. Dr. Hamrahian is located in Baltimore, Maryland. He received his medical degree from Hacettepe University in Ankara, Turkey, did his internal medicine residency at the University of North Dakota and completed his endocrinology fellowship at the Case Western Reserve University. Dr. Hamrahian is an Associate Professor of Medicine and has published more than 80 peer-reviewed articles, and has served as a co-author in developing guidelines for adrenal and pituitary disorders. He has presented at national and international conferences and has served as the principal investigator for a number of clinical research studies. Accolades received include Teacher of The Year award and Human Subject Research Annual Professional Excellence award in 2003 and 2011, respectively. Dr. Hamrahian has held roles including the chief of endocrinology in Abu Dhabi. Dr. Hamrahian is a co-director of the Adrenal Center. Dr. Hamrahian is rated as an Advanced provider by MediFind in the treatment of Adrenal Cancer. His top areas of expertise are Cushing's disease, Pituitary Tumor, Cushing's syndrome, Ectopic Cushing's syndrome, and Gamma Knife Radiosurgery.